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Introduction {#sec0005}
============

Programmed cell death plays an important role in limiting the severity of infection by multiple pathogens, but until recently, studies examining the contribution of each cell death pathway, using genetic mouse models, were largely lacking. In this review, we focus on the role of pyroptosis, apoptosis, and necroptosis during microbial infection, as they are interconnected by shared regulatory proteins and signaling pathways. Pyroptosis and necroptosis are two programmed cell death pathways that are similar in that they are lytic forms of cell death driven by activation of the pore-forming proteins gasdermin D (GSDMD) and mixed lineage kinase domain-like (MLKL), respectively. During pyroptosis, proximal sensors (including NOD-like receptor \[NLR\] pyrin-containing 1 \[NLRP1\], NLRP3, NLR family apoptosis inhibitory protein \[NAIP\]-NLR caspase recruitment domain \[CARD\]-containing 4 \[NLRC4\], Pyrin, and absent in melanoma 2 \[AIM2\]) are activated by direct ligand binding (AIM2: dsDNA; NAIP-NLRC4: type 3 secretion system \[T3SS\] needle, T3SS rod, or flagellin) or by indirect sensing of changes in cellular state (NLRP1: anthrax lethal toxin protease activity; Pyrin: Rho GTPase-inactivating toxins; NLRP3: broad range of cellular stressors including bacterial pore-forming toxins and viral infection, reviewed \[[@bib0005], [@bib0010], [@bib0015]\]). These proximal sensors may then interact with an adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC), which facilitates binding to and activation of caspase-1. Caspase-1 then proteolytically activates GSDMD, releasing its N-terminal pore-forming domain from the auto-inhibitory C-terminal domain, and cleaves the inactive pro--IL-1β and pro--IL-18 into their active forms \[[@bib0020]\]. The pore-forming activity of GSDMD then mediates pyroptotic cell lysis and release of intracellular cytokines and damage-associated molecular patterns (DAMPs). Similarly, necroptosis occurs following receptor-interacting serine/threonine-protein kinase (RIPK) 3-dependent phosphorylation of MLKL, promoting MLKL translocation to the plasma membrane and disruption of membrane integrity \[[@bib0025]\]. Unlike these lytic cell death pathways, apoptosis is often described as an ordered process characterized by cell shrinking and the blebbing off of membrane and intracellular components rather than rapid membrane disruption; this blebbing allows for inflammatory cell clearance by phagocytosis, limiting the release of intracellular cytokines and inflammatory DAMPs. Apoptosis is instigated by initiator caspase (caspase-8/9) cleavage of executioner caspases (caspases-3/6/7) which, through cleavage of a broad range of substrate proteins, drives apoptotic cell death processes \[[@bib0030]\].

In this review we will focus on PANoptosis, a unique inflammatory programmed cell death regulated by the PANoptosome ([Figure 1](#fig0005){ref-type="fig"}, [Figure 2](#fig0010){ref-type="fig"} ) \[[@bib0035], [@bib0040], [@bib0045]\]. Early studies identified that pyroptosis, via caspase-1, could cleave apoptotic caspases and poly (ADP-ribose) polymerase 1 (PARP1), that the apoptotic caspase-8 was important for the NLRP3-dependent inflammasome, and that overlap between pyroptosis, apoptosis, and necroptosis was important for different disease models, establishing a link between pyroptosis, apoptosis, and necroptosis regulators \[[@bib0050], [@bib0055], [@bib0060], [@bib0065], [@bib0070]\]. Depending on the proximal sensor of different microbial infections, the sensor molecule(s) can initiate the formation of a protein complex termed the PANoptosome, which provides a molecular scaffold that allows for interactions and activation of the machinery required for the inflammasome/pyroptosis (such as an inflammasome sensor, ASC, and caspase-1), apoptosis (caspase-8), and necroptosis (RIPK3, RIPK1) \[[@bib0040],[@bib0045],[@bib0075],[@bib0080],[@bib0085]\]. One such proximal sensor, Z-DNA-binding protein 1 (ZBP1), binds influenza A virus (IAV) viral ribonucleoproteins (vRNPs) and forms a complex called the ZBP1-dependent PANoptosome consisting of RIPK3, RIPK1, caspase-6, caspase-8, ASC, NLRP3, and caspase-1 \[[@bib0085],[@bib0090]\]. Similarly, microbial pathogen-associated molecular patterns (PAMPs), through Toll-like receptors (TLRs) or death receptor signaling (including tumor necrosis factor \[TNF\] receptor 1 \[TNFR1\], Fas, TRAIL-R, and DR3), can promote RIPK1-dependent PANoptosome formation when regulatory proteins like transforming growth factor β-activated kinase 1 (TAK1) are inhibited \[[@bib0080]\]. Similar to inflammasome complexes, which share core proteins but are also defined by their distinct proximal sensors (i.e. NLRP3 inflammasome versus NLRC4 inflammasome), distinct PANoptosomes may be named by their proximal sensors (i.e. ZBP1 PANoptosome). Together, these PANoptosome complexes promote activation of downstream cell death effectors representing pyroptosis (caspase-1 and GSDMD), apoptosis (caspase-3/7), and necroptosis (RIPK3 and MLKL). Deletion of all the PANoptosome components was required to protect macrophages from cell death during infection by multiple pathogens, suggesting it plays an important role in control of infections \[[@bib0075],[@bib0310]\]. This conceptual reframing of programmed cell death is important for understanding how the host immune system restricts pathogens in the face of adversarial microbial virulence factor manipulation of these same inflammatory signaling and cell death pathways.Figure 1Activation of PANoptosis during bacterial infection.Bacterial infection is sensed by TLRs and other innate receptors to produce NFκB-dependent inflammatory cytokines, including those of the TNF superfamily, which promote further inflammatory signaling through death receptors (including TNFR1, Fas, TRAIL-R, and DR3). Together, TLRs and death receptors signal through adaptor proteins (TRADD, FADD, RIPK1) that can engage downstream signaling pathways including TAK1 and NF-κB. In the absence of TAK1 activity, signaling through these receptors can promote cell death via RIPK1. TAK1-mediated suppression of PANoptosis is disrupted by the *Yersinia* T3SS effector YopJ, resulting in formation of a PANoptosome and activation of downstream pyroptosis, apoptosis, and necroptosis executioners as indicated. Inflammasome sensors detect their respective bacterial PAMPs and, through the adaptor ASC, can recruit and activate caspase-1/8. Black lines within proteins represent a RHIM interaction domain.Figure 1Figure 2ZBP1 as a master regulator of PANoptosis during IAV infection.ZBP1 is an innate sensor of IAV that triggers PANoptosis and inflammation. ZBP1 activation leads to its interaction with RIPK3, caspase-6, RIPK1, and caspase-8 to assemble the PANoptosome. The ZBP1-dependent PANoptosome engages NLRP3 inflammasome activation and GSDMD-dependent pyroptosis. The activation of caspase-8 leads to caspase-3, caspase-6, caspase-7 activation and apoptosis and can also cleave GSDMD, while inactivation of caspase-8 leads to phosphorylation of MLKL and necroptosis. Black lines within proteins represent the RHIM interaction domain.Figure 2

Here we will explore the physiological roles that PANoptosis plays during microbial infection and reflect on how it may be subverted by pathogens. In addition to bacterial infection, we will explore how viral pathogens also engage and manipulate multiple cell death regulators as a part of their virulence strategy and how fungal and parasitic infection may also initiate PANoptosis. Throughout, we will describe the cell death components that regulate PANoptosis during different infections, including those from pyroptosis (NLRP3, NLRC4, AIM2, ASC, caspase-1, and GSDMD), extrinsic apoptosis (TNFR1, caspase-8, caspase-3, and caspase-7), and necroptosis (TNFR1, caspase-8, RIPK1, RIPK3, and MLKL), and discuss how they play a role in PANoptosome formation. Critical regulators of these pathways, specifically molecules that regulate more than one of these defined pathways (including ZBP1, TAK1, RIPK1, and Fas-associated death domain \[FADD\]) will also be explored for their role in pathogen control. Re-evaluating the molecular determinants of cell death during infection with our updated understanding of the key molecular players is informative, as many previous studies examined cell death in immortalized cell lines, which inherently have dysregulated cell survival and cell death pathways.

PANoptosis in bacterial infection {#sec0010}
=================================

Conceptually, cell death appears to protect against most acute bacterial pathogens that infect hosts and, in many cases, even more successfully restricts non-pathogenic or opportunistic bacteria \[[@bib0095],[@bib0100]\]. Earlier studies on cell death, before the identification of many of the key regulatory genes, suggested multiple forms of cell death are induced following infection with different bacterial pathogens \[[@bib0100]\]. Armed with the current understanding of the key molecules involved in different cell death pathways and how they are extensively interconnected, future research must carefully re-examine cell death during infections. A generalized model for how bacteria may engage PANoptosis is presented in [Figure 1](#fig0005){ref-type="fig"}. Signaling through TLRs and the death receptor family members and their adaptors (including Toll/interleukin-1 receptor domain-containing adaptor-inducing interferon \[IFN\]-β \[TRIF\], MyD88, FADD, and RIPK1) coordinate the activation and inhibition of cell death through changes in gene expression, protein localization, and activation status of cell death initiator proteins. Here, we present examples of how recent research utilizing different bacterial infection models has helped to illuminate the role of cell death in pathogen control.

*Yersinia* as a model for PANoptosis in host defense {#sec0015}
----------------------------------------------------

Research into the modes of cell death activated during *Yersinia* infection has provided a useful model for understanding how PANoptosis can be activated by bacterial infection. *Yersinia* possess a T3SS effector protein, YopJ, which inhibits the host protein TAK1 \[Sweet et al., Cell Microbiol 2007; Paquette et al., PNAS 2012\].We discovered the critical role of TAK1 in cell death, showing that bone marrow-derived macrophages (BMDMs) lacking TAK1 undergo spontaneous cell death and that inhibition of TAK1 is sufficient to drive PANoptotic cell death involving caspase-8, RIPK1, RIPK3, MLKL, NLRP3, caspase-1, and GSDMD \[[@bib0115],[@bib0315],[@bib0320]\]. TAK1-deficient cells form a complex consisting of RIPK1, caspase-8, ASC, and NLRP3 that activates downstream caspases-3/7, phosphorylates MLKL, and cleaves GSDMD, causing RIPK1-dependent PANoptosis \[[@bib0080],[@bib0315],[@bib0320]\]. In the context of *Yersinia*, YopJ is secreted into macrophages and inhibits TAK1 and inhibitor of nuclear factor-κB kinase (IKK) to engage a RIPK1-- and caspase-8--dependent cleavage of GSDMD and GSDME, resulting in cell death \[[@bib0105],[@bib0110]\]. Together, the combined engagement of pyroptotic, apoptotic, and necroptotic machinery promotes intracellular clearance of *Yersinia* and release of inflammatory cytokines including IL-1β and IL-18. Depending on the cell type and the degree of inflammatory stimulation, differential expression and activation states of cell death signaling proteins are likely to dictate the relative degree to which each single cell death pathway is activated. The activation of PANoptosis during *Yersinia* infection is critical for the destruction of the intracellular niche and bacterial clearance.

Complex interplay of bacterial effectors and PANoptosis {#sec0020}
-------------------------------------------------------

As with *Yersinia*, *Salmonella enterica* serovar Typhimurium has been shown to both activate and regulate PANoptosis \[[@bib0075]\]. Canonical pyroptotic ligands including the T3SS needle and rod proteins and flagellin each activate the NAIP-NLRC4 inflammasomes \[[@bib0120], [@bib0125], [@bib0130]\]. Similar to *Yersinia*, *Salmonella* T3SS effector proteins (AvrA, SspH1, SseL, GtgA, SpvC, SopB, SseK1/4) extensively inhibit TLR-mediated and TNF-mediated inflammatory signaling. Similar to *Yersinia*'s YopJ, *Salmonella* effector proteins may balance the production of inflammatory mediators and, in some cells, may trigger a PANoptotic cell death response as a consequence \[[@bib0135]\]. Despite the activity of many of the immunomodulatory effectors secreted by *Salmonella*, NLRC4 inflammasome activation readily occurs and can recruit NLRP3 to a combined inflammasome complex \[[@bib0140]\], which could potentially recruit other PANoptosome components to drive cell death. Indeed, this complex has also been shown to recruit caspase-8, and FADD/caspase-8 have both been shown to regulate the priming and activation of NLRP3-dependent inflammasome activation during infection \[[@bib0060],[@bib0145]\]. In addition, *Salmonella* lipopolysaccharide (LPS) can be exposed from the *Salmonella*-containing vesicle by IFN-mediated expression of guanylate binding proteins (GBPs), which lyse the intracellular vacuole and allow caspase-11 sensing of LPS and activation of GSDMD, promoting additional NLRP3-dependent inflammasome activation \[[@bib0150],[@bib0155]\]. Activation of TLR/TNF signaling during infection, in combination with variable expression of apoptosis-regulatory proteins, may also promote necroptosis, which has been suggested by data showing that MLKL phosphorylation occurs during BMDM infection \[[@bib0075],[@bib0160]\]. Interestingly, caspase-8--mediated suppression of necroptosis during intestinal *Salmonella* infection appears to be important for limiting excessive inflammatory damage in the host, suggesting cell-specific and tissue-specific responses should be carefully examined depending on the particular microbe \[[@bib0165]\].

Similar to *Salmonella*, enteropathogenic *Escherichia coli* (EPEC) possess T3SS effectors that block various arms of regulated cell death. NleB and NleF inhibit death receptor-mediated apoptosis and necroptosis by negatively regulating death domain (DD) interactions between FADD, TRADD, RIPK1, and caspase-8 or by directly inhibiting caspase activity, while EspL restricts necroptosis and pyroptosis via proteolytic cleavage of the receptor-interacting protein homotypic interaction motif (RHIM) domains of RIPK1, RIPK3, TRIF, and ZBP1. Loss of these effectors consequently may allow for increased activation of PANoptosis \[[@bib0170], [@bib0175], [@bib0180]\]. Other bacteria, including *Listeria monocytogenes* and *Francisella novicida*, also have the potential to activate multiple cell death processes \[[@bib0075],[@bib0185],[@bib0190]\]. *Francisella* infection activates the AIM2 inflammasome, and recent studies have identified that AIM2, through ASC, can also promote apoptosis via caspase-8 \[[@bib0195]\]. *Francisella*-induced IFNs also promote expression of TRAIL, which signals through death receptors to promote apoptosis \[[@bib0190]\]. Highly virulent species of *Francisella* have also been described to induce necroptosis, but the molecular mechanisms of this are poorly studied \[[@bib0200]\]. Together, these overlapping modes of cell death activation provide another example of how PANoptosis can restrict infection by a wide range of bacteria possessing a wide range of PAMPs and virulence regulators.

PANoptosis in viral infection {#sec0025}
=============================

PANoptosis plays a key role in viral infection and functions as an antiviral strategy restricting a variety of viruses. Here, we present examples of recent research utilizing different viral infection models that have helped to illuminate the role of multiple cell death pathways in pathogen control.

Influenza A virus (IAV) as a model for PANoptosis in host defense {#sec0030}
-----------------------------------------------------------------

Recently, ZBP1 has been identified as a sensor of IAV vRNPs that triggers PANoptosis ([Figure 2](#fig0010){ref-type="fig"}) \[[@bib0090]\]. During infection, ZBP1 interacts with RIPK3 via the RHIM domain and recruits caspase-8 and the NLRP3 inflammasome sensor to promote assembly of a PANoptosome complex that drives PANoptosis \[[@bib0090],[@bib0205], [@bib0210], [@bib0215]\]. The ZBP1-dependent PANoptosome is required for NLRP3-- and capsase-1--dependent inflammasome activation, pyroptosis, and maturation of proinflammatory cytokines including IL-1β and IL-18 during IAV infection. IAV infection also results in activation of apoptotic caspases-8, caspases-3, and caspases-7. Inhibition of caspase activity during IAV infection, with the pan-caspase inhibitor z-VAD, promotes necroptosis \[[@bib0090]\]. More recently, caspase-6 was identified as a PANoptosome component that facilitates RHIM-dependent binding of RIPK3 with ZBP1, promoting ZBP1-mediated PANoptosis \[[@bib0085]\].

Similar to how bacteria engage PANoptotic regulators through activation of TLR/TNF signaling and regulation of RIPK1 activation states, ZBP1 is regulated by upstream innate immune sensors. IAV RNA sensing by RIG-I or TLR3 results in expression of type I IFNs and signaling through the type I IFN receptor (IFNAR), upregulation of IFN regulatory factor 1 (IRF1), and IRF1-dependent ZBP1 expression \[[@bib0205],[@bib0220]\]. Structurally, ZBP1 contains two nucleic acid Zα binding domains which were initially described to bind DNA in the Z-conformation and have been proposed to sense other nucleic acids (including vRNPs) in a conformation-dependent manner \[[@bib0205],[@bib0225]\]. Once expressed, ZBP1 functions as a sensor of IAV infection by interacting with vRNP complexes (consisting of viral polymerases \[PA, PB1, PB2\], NP, and viral RNA) in the cytoplasm and forms a ZBP1-dependent PANoptosome \[[@bib0085],[@bib0090],[@bib0215]\]. Cytoplasmic ZBP1 can translocate to the nucleus where viral genome replication occurs, indicating that sensing of IAV can occur in either the nucleus or the cytoplasm. Indeed, a recent study found that replicating IAV Z-RNAs are recognized by the Zα2 domain of ZBP1 in the nucleus of infected cells as viral nucleic acid ligands, which activate RIPK3 and MLKL, resulting in MLKL-dependent nuclear envelope rupture and necroptosis \[[@bib0210],[@bib0230]\]. It remains unclear whether the Z-RNAs sensed by ZBP1 in the nucleus can assemble a PANoptosome in the cytoplasm. Taken together, these studies demonstrate ZBP1 interactions with various components of IAV to induce PANoptosis.

ZBP1-mediated PANoptosis in response to other viral pathogens {#sec0035}
-------------------------------------------------------------

Although ZBP1 regulates PANoptosis in response to both mouse-adapted and human IAV strains, other RNA viruses including vesicular stomatitis virus (VSV), Sendai virus (SeV), and respiratory syncytial virus (RSV) do not appear to activate ZBP1-dependent PANoptosis \[[@bib0090],[@bib0235]\]. While ZBP1 has not been shown to be required for cell death during infection with VSV, loss of key PANoptotic components including caspase-1/11, RIPK3, and caspase-8 reduces the amount of cell death observed during VSV infection \[[@bib0075]\]. Additionally, cells require caspase-8/RIPK3 to induce PANoptosis during infection with the coronavirus murine hepatits virus (MHV), a model for studying coronavirus infections \[[@bib0310]\], though the role of ZBP1 remains unclear in this context. These data suggest that, unlike ZBP1-dependent activation of PANoptosis through direct sensing of IAV infection, innate receptor signaling through TLRs, TNFR1, and/or other unidentified sensors may initiate PANoptosis in other viral infections.

PANoptosis in viral pathogenesis {#sec0040}
--------------------------------

PANoptosis can be beneficial to the host as it triggers the infiltration of immune cells to remove infectious viral agents. However, excessive PANoptosis may also drive detrimental inflammation and tissue damage without an apparent benefit to the host. For example, ZBP1-dependent PANoptosis restricts replication of IAV but also contributes to virus-induced lung immunopathology \[[@bib0220],[@bib0235],[@bib0240]\]. ZBP1 is also important for the restriction of West Nile virus and Zika virus infection \[[@bib0245],[@bib0250]\], but the role of PANoptosis is poorly understood. The balance of ZBP1-dependent PANoptosis and immunopathology is also highlighted by recent work showing that caspase-6, which promotes PANoptosis, is important for limiting IAV-induced lung immunopathology, presumably by promoting ZBP1-dependent PANoptosis \[[@bib0085]\]. Together, these findings highlight how virus-induced PANoptosis must be balanced to reduce excessive inflammation while retaining antiviral functions. These studies indicate that activation or suppression of PANoptosis may be therapeutically targeted to improve viral infection outcomes in the future.

Complex interplay of viral modulators of PANoptosis {#sec0045}
---------------------------------------------------

Because of the importance of PANoptotic cell death in limiting viral replication and promoting clearance, viruses have undergone selective pressure to limit PANoptosis and permit their intracellular replication. Several viruses encode proteins that interfere with PANoptotic signaling \[[@bib0255]\]. MCMV-encoded viral inhibitor of RIP activation (vIRA), the product of the *M45* gene, is a potent RHIM-containing cell death suppressor that targets ZBP1, RIPK3, and RIPK1 \[[@bib0235]\], potentially restricting PANoptosome formation to evade PANoptosis. The HSV-1 protein ICP6 has a key role in restricting ZBP1-dependent cell death in human cells; however, this is not the case in murine cells, suggesting that host--pathogen adaptations may be driven by viral-mediated inhibition of PANoptosis \[[@bib0260]\]. These studies suggest that viruses have undergone selection to evade host cell PANoptosis, and these adaptations potentially help define the host range of different viruses. Future research may reveal inhibitors of these viral PANoptosis regulators that have therapeutic applications for treating viral infection.

PANoptosis in fungal and parasitic infections {#sec0050}
=============================================

While the majority of studies have focused on bacterial and viral pathogens which activate PANoptosis during infection, conceptually fungal and parasitic infections could result in similar cell death outcomes. Inflammatory signaling mediated by TLRs and death receptor family members is conserved during these infections. In addition, fungal pathogens such as *Aspergillus fumigatus* and *Candida albicans* activate the innate C-type lectin receptors (CLRs). Through these CLRs, fungi engage the molecule SYK, which drives formation of a molecular complex consisting of CARD9, BCL10, MALT1, ASC, caspase-8, NLRP3, AIM2, and caspase-1, which together likely promote PANoptosis \[[@bib0265], [@bib0270], [@bib0275], [@bib0280], [@bib0285]\]. The apicomplexan pathogen *Toxoplasma gondii* activates pyroptosis via NLRP1b and, similar to fungal infection, activates the SYK-CARD9 signaling axis to promote NLRP3/ASC/caspase-1 inflammasome activation and GSDMD-independent cell death, suggesting other gasdermin family members or other PANoptosis signaling components converge to restrict this parasitic infection \[[@bib0290],[@bib0295]\]. These findings suggest that PANoptosis plays important roles in the host response to a wide variety of microbial agents.

Summary and future directions {#sec0055}
=============================

The concept of PANoptosis can be leveraged to improve our understanding of selection pressures and protein--protein interactions among different pathogen--host pairs, emphasizing the importance of this programmed cell death process. While here we largely explored examples of acute infectious agents, the same framework can be used to understand the strategies of chronic infectious agents as well as commensal, zoonotic, and opportunistic infections. This concept is also applicable to both extracellular and intracellular pathogens, as many microbes considered to be largely extracellular have been shown to activate the NLRP3 inflammasome \[[@bib0020]\], potentially through activation of a hypothetical PANoptosome not requiring direct microbial ligand sensing. Recent work utilizing *Casp1/11* ^−/−^ *Casp8* ^−/−^ *Ripk3* ^−/−^ mice also provides genetic evidence for PANoptosome components regulating cell death during infections of BMDMs with *Salmonella*, *Listeria*, IAV, and VSV \[[@bib0075]\]. Additionally, in a murine colorectal cancer model, IRF1-dependent activation of PANoptosis prevents AOM/DSS-induced colorectal tumorigenesis, suggesting a broader role for PANoptosis in cancer \[[@bib0300]\]. Adaptive immune responses may also promote clearance of pathogens through cooperation with PANoptosis, as CD8^+^ T cells produce death receptor cytokines and lyse infected cells via secretion of perforin, which promotes NLRP3-dependent inflammasome activation \[[@bib0305]\]. Characterization of the interactions between microbial virulence factors and the many regulatory proteins known to modulate inflammatory signaling are likely to reveal unique mechanisms of PANoptosis activation. Considering the critical role PANoptosis plays in controlling multiple microbial infections, future studies should reveal new treatment strategies to both control infection and minimize inflammatory pathology with benefits to the host.
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